Boston Scientific Announces Results For First Quarter 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
Go back to Boston Scientific Announces Results For First Quarter 2021
April 28, 2021 1:17 PM EDT
BTIG analyst Marie Thibault raised the price target on Boston Scientific (NYSE: BSX) to $48.00 (from $44.00) while maintaining a Buy rating.
The analyst commented, "Despite what we felt were high expectations for Boston Scientifics Q1 print, the company easily beat consensus estimates and exceeded the high end of the guidance range. BSX also posted y/y growth over 2019 comps and... More
April 28, 2021 11:30 AM EDT
Piper Sandler analyst Matt O'Brien raised the price target on Boston Scientific (NYSE: BSX) to $51.00 (from $46.00) while maintaining an Overweight rating.
...
More
April 28, 2021 6:32 AM EDT
Boston Scientific (NYSE: BSX) reported Q1 EPS of $0.37, $0.06 better than the analyst estimate of $0.31. Revenue for the quarter came in at $2.75 billion versus the consensus estimate of $2.62 billion.
GUIDANCE:
Boston Scientific sees Q2 2021 EPS of $0.36-$0.38, versus the consensus of $0.35.
The company now estimates net sales growth for the full year 2021, versus the prior year period, to be in a...
More
